Overige zenuwstelsel-aandoeningen: demyeliniserende aandoeningen (MS), neoplasmata en epilepsie Stroke
Conditions
Interventions
None listed
Sponsors
Universitair Medisch Centrum Utrecht
Eligibility
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: In order to be eligible to participate in this study, a patient must meet the following criteria: • Age >= 18 years • Diagnosed with one of the following neurological diseases: primary brain tumor, epilepsy, MS or ischemic stroke • Previous imaging findings characteristic of particular neurological disease • Ability to lie supine in the MRI scanner for 45 minutesAlthough not an inclusion criterion, care is taken to select those patients that are already scheduled for a standard clinical follow-up MRI examination within the next 4 months, thereby limiting patient burden by providing the option to combine both study- and clinical MRI examination on the same day.Inclusion criteria for healthy volunteers are the following: • Age >= 18 years • No history of neurological diseases
Exclusion criteria
Exclusion criteria: Patients will be excluded when meeting one of the following criteria: • Atypical imaging findings not characteristic for the neurological diagnosisExclusion criteria for the healthy volunteers are as follows: • History of any neurological disease
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The main study parameter will be the image quality scores of the MR-STAT-generated image data sets with regard to overall image quality, image artifacts, and visualization of several predefined anatomical structures; these scores will be compared with those of the standard MRI data sets. | — |
Secondary
| Measure | Time frame |
|---|---|
| The secondary study parameter will be the image quality of the MR-STAT-generated image data sets compared with the standard MRI data sets, assessed in a side-by-side fashion. | — |
Countries
Netherlands
Outcome results
None listed